CN108254570A - 甲胎蛋白定量检测试剂盒 - Google Patents

甲胎蛋白定量检测试剂盒 Download PDF

Info

Publication number
CN108254570A
CN108254570A CN201711460989.4A CN201711460989A CN108254570A CN 108254570 A CN108254570 A CN 108254570A CN 201711460989 A CN201711460989 A CN 201711460989A CN 108254570 A CN108254570 A CN 108254570A
Authority
CN
China
Prior art keywords
fetoprotein
alpha
control product
detection reagent
quantitative detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711460989.4A
Other languages
English (en)
Inventor
周丕靖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Green Wo Yimin Biomass Utilization Technology Co Ltd
Original Assignee
Tianjin Green Wo Yimin Biomass Utilization Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Green Wo Yimin Biomass Utilization Technology Co Ltd filed Critical Tianjin Green Wo Yimin Biomass Utilization Technology Co Ltd
Priority to CN201711460989.4A priority Critical patent/CN108254570A/zh
Publication of CN108254570A publication Critical patent/CN108254570A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

本发明公开了甲胎蛋白定量检测试剂盒，其特征在于，所述试剂盒包括：甲胎蛋白抗体包被板、甲胎蛋白抗体酶结合物、甲胎蛋白校准品、甲胎蛋白质控品、20倍浓缩洗液。本发明的优点是：检测速度快，能快速检测处是否有甲胎蛋白，检测准确，灵敏度高，易操作。

Description

甲胎蛋白定量检测试剂盒
技术领域
本发明涉及免疫分析医学领域，具体的涉及甲胎蛋白定量检测试剂盒。
背景技术
甲胎蛋白(AFP)是一种糖蛋白，属于白蛋白家族，主要由胎儿肝细胞 及卵黄囊合成。甲胎蛋白在胎儿血液循环中具有较高的浓度，出生后则下降， 至生后2～3月甲胎蛋白基本被白蛋白替代，血液中较难检出，故在成人血 清中含量极低。甲胎蛋白具有很多重要的生理功能，包括运输功能、作为生 长调节因子的双向调节功能、免疫抑制、T淋巴细胞诱导凋亡等。甲胎蛋白 与肝癌及多种肿瘤的发生发展密切相关，在多种肿瘤中均可表现出较高浓 度，可作为多种肿瘤的阳性检测指标。目前临床上主要作为原发性肝癌的血 清标志物，用于原发性肝癌的诊断及疗效监测。
试剂盒用于盛放检测化学成分、药物残留、病毒种类等化学试剂的盒 子。一般医院、制药企业使用。
目前甲胎蛋白的试剂盒检测准确率较差。
发明内容
本发明的目的在于克服现有技术的不足，提供一种快速检测甲胎蛋白的 试剂盒。
本发明通过以下方案实现：
甲胎蛋白定量检测试剂盒，所述试剂盒包括：甲胎蛋白抗体包被板、 甲胎蛋白抗体酶结合物、甲胎蛋白校准品、甲胎蛋白质控品、20倍浓缩洗 液。
优选的，所述的甲胎蛋白抗体包被板为包被有甲胎蛋白抗体的96孔或 48孔的白色微孔板，白色微孔板的孔间平均变异不高于7％。
优选的，所述的抗体酶结合物所用的酶为辣根过氧化物酶，纯度要求 RZ≥2.5，活性≥260U/mL。
优选的，甲胎蛋白质控品包括低值质控品和高值质控品，其中低值质 控品的浓度范围9ng/mL，高值质控品的浓度范围是130ng/mL。
优选的，所述的20倍浓缩洗液包括75.5g/LTris，120g/LNaCl， 5mL/LTween-20，1g/LProclin300。
本发明的优点是：检测速度快，能快速检测处是否有甲胎蛋白，检测准 确，灵敏度高，易操作。
具体实施方式
为了使本发明上述特征和优点更加清楚和容易理解，对本发明的实施方 式作进一步详细描述。
实施例1
甲胎蛋白定量检测试剂盒，所述试剂盒包括：甲胎蛋白抗体包被板、 甲胎蛋白抗体酶结合物、甲胎蛋白校准品、甲胎蛋白质控品、20倍浓缩洗 液。
优选的，所述的甲胎蛋白抗体包被板为包被有甲胎蛋白抗体的96孔或 48孔的白色微孔板，白色微孔板的孔间平均变异不高于7％。
优选的，所述的抗体酶结合物所用的酶为辣根过氧化物酶，纯度要求 RZ≥2.5，活性≥260U/mL。
优选的，甲胎蛋白质控品包括低值质控品和高值质控品，其中低值质 控品的浓度范围9ng/mL，高值质控品的浓度范围是130ng/mL。
优选的，所述的20倍浓缩洗液包括75.5g/LTris，120g/LNaCl， 5mL/LTween-20，1g/LProclin300。
以上所述仅为本发明创造的较佳实施例而已，并不用以限制本发明创 造，凡在本发明创造的精神和原则之内，所作的任何修改、等同替换、改进 等，均应包含在本发明创造的保护范围之内。

Claims (5)

1.甲胎蛋白定量检测试剂盒，其特征在于，所述试剂盒包括：甲胎蛋白抗体包被板、甲胎蛋白抗体酶结合物、甲胎蛋白校准品、甲胎蛋白质控品、20倍浓缩洗液。
2.根据权利要求1所述的甲胎蛋白定量检测试剂盒，其特征在于，所述的甲胎蛋白抗体包被板为包被有甲胎蛋白抗体的96孔或48孔的白色微孔板，白色微孔板的孔间平均变异不高于7％。
3.根据权利要求1所述的甲胎蛋白定量检测试剂盒，其特征在于，所述的抗体酶结合物所用的酶为辣根过氧化物酶，纯度要求RZ≥2.5，活性≥260U/mL。
4.根据权利要求1所述的甲胎蛋白定量检测试剂盒，其特征在于，甲胎蛋白质控品包括低值质控品和高值质控品，其中低值质控品的浓度范9ng/mL，高值质控品的浓度范围是130ng/mL。
5.根据权利要求1所述的甲胎蛋白定量检测试剂盒，其特征在于，所述的20倍浓缩洗液包括75.5g/LTris，120g/LNaCl，5mL/LTween-20，1g/LProclin300。
CN201711460989.4A 2017-12-28 2017-12-28 甲胎蛋白定量检测试剂盒 Pending CN108254570A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711460989.4A CN108254570A (zh) 2017-12-28 2017-12-28 甲胎蛋白定量检测试剂盒

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711460989.4A CN108254570A (zh) 2017-12-28 2017-12-28 甲胎蛋白定量检测试剂盒

Publications (1)

Publication Number Publication Date
CN108254570A true CN108254570A (zh) 2018-07-06

Family

ID=62724305

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711460989.4A Pending CN108254570A (zh) 2017-12-28 2017-12-28 甲胎蛋白定量检测试剂盒

Country Status (1)

Country Link
CN (1) CN108254570A (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102095868A (zh) * 2009-12-11 2011-06-15 上海裕隆生物科技有限公司 甲胎蛋白化学发光定量检测试剂盒
CN102866254A (zh) * 2012-09-21 2013-01-09 潍坊市康华生物技术有限公司 一种高灵敏度孕中期唐氏综合症产前筛查试剂盒及其制备和检测方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102095868A (zh) * 2009-12-11 2011-06-15 上海裕隆生物科技有限公司 甲胎蛋白化学发光定量检测试剂盒
CN102866254A (zh) * 2012-09-21 2013-01-09 潍坊市康华生物技术有限公司 一种高灵敏度孕中期唐氏综合症产前筛查试剂盒及其制备和检测方法

Similar Documents

Publication Publication Date Title
Tang et al. Methionine metabolism is essential for SIRT 1‐regulated mouse embryonic stem cell maintenance and embryonic development
Huang et al. Correlation of ALDH 1, CD 44, OCT 4 and SOX 2 in tongue squamous cell carcinoma and their association with disease progression and prognosis
Kaja et al. Quantification of lactate dehydrogenase for cell viability testing using cell lines and primary cultured astrocytes
Ho et al. Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay
Remsing Rix et al. Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells
Shahid et al. Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling
Lassen et al. HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
Liang et al. High-content analysis provides mechanistic insights into the testicular toxicity of bisphenol A and selected analogues in mouse spermatogonial cells
Mandavilli et al. Detection of intracellular glutathione using ThiolTracker violet stain and fluorescence microscopy
Yu et al. ALKBH5-mediated m6A demethylation of lncRNA RMRP plays an oncogenic role in lung adenocarcinoma
Fujimoto et al. Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosis
McLaren et al. Automated large-scale culture and medium-throughput chemical screen for modulators of proliferation and viability of human induced pluripotent stem cell–derived neuroepithelial-like stem cells
Lee et al. Elevated snail expression mediates tumor progression in areca quid chewing-associated oral squamous cell carcinoma via reactive oxygen species
Chen et al. Low-folate stress reprograms cancer stem cell-like potentials and bioenergetics metabolism through activation of mTOR signaling pathway to promote in vitro invasion and in vivo tumorigenicity of lung cancers
Park et al. Pulsed SILAC-based proteomic analysis unveils hypoxia-and serum starvation-induced de novo protein synthesis with PHD finger protein 14 (PHF14) as a hypoxia sensitive epigenetic regulator in cell cycle progression
Galenkamp et al. Quantitation of macropinocytosis in cancer cells
Han et al. Iron overload inhibits self‐renewal of human pluripotent stem cells via DNA damage and generation of reactive oxygen species
CN108254570A (zh) 甲胎蛋白定量检测试剂盒
Rindone et al. Metformin counteracts the effects of FSH on rat Sertoli cell proliferation
Yoshie et al. Evaluation of biological effects of intermediate frequency magnetic field on differentiation of embryonic stem cell
Smith et al. Delayed rectifier and A-type potassium channels associated with Kv 2.1 and Kv 4.3 expression in embryonic rat neural progenitor cells
CN102279264A (zh) 48种恶性肿瘤标志物抗体芯片的制备方法
Kong et al. Impact of collection, isolation and storage methodology of circulating microvesicles on flow cytometric analysis
Papkovsky et al. Cell energy budget platform for multiparametric assessment of cell and tissue metabolism
Lee et al. Novel three-dimensional cultures provide insights into thyroid cancer behavior

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180706

RJ01 Rejection of invention patent application after publication